Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 3/20 | 0.49 |
| ▸ | MVD | P53602 | 4/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | FNTA | P49354 | 4/20 | 0.35 |
| ▸ | FNTB | P49356 | 2/20 | 0.35 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.35 |
| ▸ | PGGT1B | P53609 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3677401 | 0.85 | BTN3A1 (0.49) | BTN3A1MVDFNTAFNTBGGPS1 | |
| SCHEMBL155704 | 0.82 | BTN3A1 (0.53) | BTN3A1MVDFNTAFNTBGGPS1 | |
| SCHEMBL155705 | 0.82 | BTN3A1 (0.53) | BTN3A1MVDFNTAFNTBGGPS1 | |
| SCHEMBL3775300 | 0.81 | BTN3A1 (0.52) | BTN3A1MVDFNTAFNTBGGPS1 | |
| SCHEMBL22319797 | 0.81 | BTN3A1 (0.45) | BTN3A1MVDFNTAFNTBGGPS1 | |
| SCHEMBL21310680 | 0.81 | MVD (0.50) | BTN3A1MVDFNTAFNTB | |
| SCHEMBL22319792 | 0.81 | BTN3A1 (0.45) | BTN3A1MVDFNTAFNTBGGPS1 | |
| SCHEMBL27897700 | 0.79 | BTN3A1 (0.50) | BTN3A1MVDFNTAFNTBGGPS1 | |
| SCHEMBL22235275 | 0.77 | BTN3A1 (0.54) | BTN3A1FNTAFNTBGGPS1PGGT1B | |
| SCHEMBL6690483 | 0.77 | BTN3A1 (0.54) | BTN3A1FNTAFNTBGGPS1PGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3681504-B1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN INC (US) | 2023-08-23 | — | — | EP | disclosed |
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| US-10877035-B2 | Advanced drug development and manufacturing | ICAGEN, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| US-20200278346-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ADJACENT ACQUISITION CO., LLC | 2020-09-03 | — | — | US | disclosed |
| EP-3681504-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | Icagen, Inc. (US) | 2020-07-22 | — | — | EP | disclosed |
| WO-2019055754-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN, INC. (US) | 2019-03-21 | — | — | WO | disclosed |
| US-20150309021-A1 | Advanced Drug Development and Manufacturing | LOS ALAMOS NATIONAL SECURITY, LLC | 2015-10-29 | — | — | US | disclosed |
| EP-2511844-B1 | X-ray microscope | XRPRO SCIENCES INC (US) | 2015-08-12 | — | — | EP | disclosed |
| US-20080220441-A1 | Advanced drug development and manufacturing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-09-11 | — | — | US | disclosed |